Weighted Average Number of Shares Outstanding, Diluted of Allarity Therapeutics, Inc. from 30 Sep 2020 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Allarity Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2020 to 30 Jun 2024.
  • Allarity Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2024 was 14,979,095, a 80342% increase year-over-year.
  • Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1,990,748, a 29154% increase from 2022.
  • Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6,805, a 100% decline from 2021.
  • Allarity Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 6,358,988, a 95% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Allarity Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 14,979,095 +14,960,474 +80342% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 175,266 +174,738 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 1,990,748 +1,983,943 +29154% 01 Oct 2023 31 Dec 2023 10-K 08 Mar 2024 2023 FY
Q3 2023 2,474,724 +2,467,571 +34497% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 18,621 -101,602 -85% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 528* -236,283 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 6,805 01 Oct 2022 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q3 2022 7,153 -7,745,898 -100% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 120,223 -4,896,960 -98% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 236,811 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q3 2021 7,753,051 +4,028,434 +108% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 5,017,183 01 Apr 2021 30 Jun 2021 10-Q 07 Oct 2022 2022 Q2
Q3 2020 3,724,617 01 Jul 2020 30 Sep 2020 10-Q/A 17 May 2022 2021 Q3

Allarity Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 1,990,748 +1,983,943 +29154% 01 Jan 2023 31 Dec 2023 10-K 08 Mar 2024 2023 FY
2022 6,805 -6,352,183 -100% 01 Jan 2022 31 Dec 2022 10-K 08 Mar 2024 2023 FY
2021 6,358,988 +3,094,208 +95% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2023 2022 FY
2020 3,264,780 01 Jan 2020 31 Dec 2020 10-K 17 May 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.